EUVIMEDEUVIMED entdecken
Crossref

miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis

Tuba Gökdoğan Edgünlü, Şenay Görücü Yılmaz iD, Ufuk Emre, Bahar Taşdelen, Oktay Kuru, Gülnihal Kutlu, Mehmet Emin Erdal

Genome · 01.11.2022 · 65 (11) · 547-561

DOI: 10.1139/gen-2022-0040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome, erschienen am 01.11.2022. Verfasst von Tuba Gökdoğan Edgünlü und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Medical Faculty, Muğla Sıtkı Koçman University, Muğla, Turkey. Hauptthemen laut MEDLINE: Multiple Sclerosis, MicroRNAs. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterized by demyelination and axonal degeneration. Abnormal expression of microRNAs (miRNAs) plays an important role in MS pathology. In this cohort study, differential expression of the four miRNAs ( hsa-miR-155-5p, hsa-miR-9-5p, hsa-miR-181a-5p, and hsa-miR-125b-5p) was investigated in 69 individuals, including 39 MS patients (relapsing-remitting MS (RRMS), n = 27; secondary progressive MS (SPMS), n = 12) and 30 healthy controls. In silico analyses revealed possible genes and pathways specific to miRNAs. Peripheral blood miRNA expressions were detected by quantitative real-time PCR (qPCR). hsa-miR-181a-5p was downregulated and associated with increased MS risk ( P = 0.012). The other three miRNAs were upregulated and not associated with MS ( P < 0.05). The area under the curve (AUC) is 0.779. In silico analyses showed that hsa-miR-181a-5p may participate in MS pathology by targeting MAP2K1, CREB1, ATXN1, and ATXN3 genes in inflammation and neurodegeneration pathways. The circulatory hsa-miR-181a-5p can regulate target genes, reversing the mechanisms involved in MS pathologies such as protein uptake and processing, cell proliferation and survival, inflammation, and neurodegeneration. Thus, this miRNA could be used as an epigenomic-guided diagnostic tool and for therapeutic purpose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisMicroRNAsHumansEpigenomicsCohort StudiesBiomarkersInflammationEpigenesis, Genetic

Stichwörter der Autor:innen

diagnostic moléculaire du sang périphériquemiARN biomarqueursmiRNA biomarkersmultiple sclerosisperipheral blood molecular diagnosticssclérose en plaques

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Medical Biology, Medical Faculty, Muğla Sıtkı Koçman University, Muğla, Turkey.
  • Department of Nutrition and Dietetics, Health Sciences Faculty, Gaziantep University, Gaziantep, Turkey.
  • Department of Neurology, Istanbul Education and Research Hospital, Istanbul, Turkey.
  • Department of Biostatistics and Information, Medical Faculty, Mersin University, Mersin, Turkey.
  • Department of Physiotherapy and Rehabilitation, Health Sciences Faculty, Muğla Sıtkı Koçman University, Muğla, Turkey.
  • Department of Neurology, Medical Faculty, Muğla Sıtkı Koçman University, Muğla, Turkey.

ORCID-Profile: Şenay Görücü Yılmaz

Zitieren

APA

Edgünlü, T. G., Yılmaz, Ş. G., Emre, U., Taşdelen, B., Kuru, O., Kutlu, G., & Erdal, M. E. (2022). miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis. Genome, 65(11), 547-561. https://doi.org/10.1139/gen-2022-0040

Vancouver

Edgünlü TG, Yılmaz ŞG, Emre U, Taşdelen B, Kuru O, Kutlu G, et al. miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis. Genome. 2022;65(11):547-561. doi:10.1139/gen-2022-0040

BibTeX
@article{Edgnl2022,
  author = {Edgünlü, Tuba Gökdoğan and Yılmaz, Şenay Görücü and Emre, Ufuk and Taşdelen, Bahar and Kuru, Oktay and Kutlu, Gülnihal and Erdal, Mehmet Emin},
  title = {miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis},
  journal = {Genome},
  year = {2022},
  volume = {65},
  number = {11},
  pages = {547--561},
  doi = {10.1139/gen-2022-0040}
}
Kostenlos starten →